Match each clinical presentation of a patient with a gynecologic infection to the most appropriate next best step in management.
- A 30-year-old nonpregnant woman who presents with her fourth culture-confirmed episode of vulvovaginal candidiasis in the past year.Induction therapy with multiple doses of oral fluconazole followed by a 6-month suppressive course of weekly fluconazole
- A 32-year-old woman with mild, uncomplicated pelvic inflammatory disease who currently has a copper intrauterine device (IUD) in place.Outpatient management with intramuscular ceftriaxone, oral doxycycline, and oral metronidazole; the intrauterine device may remain in place
- A 27-year-old pregnant woman at 14 weeks gestation who tests positive for Chlamydia trachomatis during routine cervical screening.Treatment with oral azithromycin or amoxicillin, followed by a test of cure in 3 to 4 weeks
- A 19-year-old pregnant woman at 8 weeks gestation who presents with lower abdominal pain, cervical motion tenderness, and is diagnosed with acute pelvic inflammatory disease.Hospitalization for parenteral antibiotic therapy using a regimen that avoids tetracyclines (e.g., intravenous clindamycin and gentamicin)
- A 35-year-old woman with a 6-cm tubo-ovarian abscess who continues to have spiking fevers and worsening pain after 72 hours of appropriate intravenous antibiotics.Image-guided percutaneous or transvaginal drainage of the adnexal mass
Answer
Each clinical presentation must be matched with its guideline-concordant next step: Recurrent VVC requires suppressive fluconazole; mild PID with an IUD is treated outpatient without IUD removal; Chlamydia in pregnancy requires a test of cure; PID in pregnancy requires hospitalization with non-teratogenic IV antibiotics; and a refractory TOA requires drainage.
The correct matches synthesize CDC guidelines for gynecologic infections, specifically testing the high-yield exceptions and complicated scenarios: prolonged suppressive therapy for recurrent candidiasis, retaining the IUD in acute PID, avoiding teratogens while mandating a test of cure in pregnancy, and escalating to drainage for refractory tubo-ovarian abscesses.
Step-by-Step Solution
Key Concept
Complex management of gynecologic infections requires adapting standard guidelines to account for pregnancy (avoiding teratogens, mandating tests of cure), treatment refractoriness (TOA drainage), recurrent disease patterns, and foreign bodies (IUD retention).